171 related articles for article (PubMed ID: 32125400)
1. Rebates-The Little-Known Factor Behind Increasing Drug List Prices.
Rubin R
JAMA; 2020 Mar; 323(9):812-813. PubMed ID: 32125400
[No Abstract] [Full Text] [Related]
2. Lowering Part D drug costs without direct CMS negotiations.
Sipkoff M
Manag Care; 2009 Sep; 18(9):11-2. PubMed ID: 19886203
[No Abstract] [Full Text] [Related]
3. A New Safe Harbor - Turning Drug Rebates into Discounts in Medicare Part D.
Gellad WF; Ennis M; Kuza CC
N Engl J Med; 2019 May; 380(18):1688-1690. PubMed ID: 30946552
[No Abstract] [Full Text] [Related]
4. How insurers' bargaining power affects drug prices in Medicare Part D.
Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
[No Abstract] [Full Text] [Related]
5. Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices.
Dusetzina SB; Keating NL; Huskamp HA
N Engl J Med; 2019 Oct; 381(15):1401-1404. PubMed ID: 31483987
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
[No Abstract] [Full Text] [Related]
7. Remember the MaineRx.
Kemp R
Appl Health Econ Health Policy; 2014 Feb; 12(1):1-5. PubMed ID: 24420789
[TBL] [Abstract][Full Text] [Related]
8. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
Greene JA; Padula WV
N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
[No Abstract] [Full Text] [Related]
9. Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle.
Dusetzina SB; Bach PB
JAMA; 2019 Apr; 321(16):1563-1564. PubMed ID: 30840047
[No Abstract] [Full Text] [Related]
10. CMS retreats on Part D rule intended to reduce drug costs and improve access.
Dickson V
Mod Healthc; 2014 Mar; 44(11):10. PubMed ID: 24830094
[No Abstract] [Full Text] [Related]
11. A few specialty drug prices fall--all generics.
Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
[No Abstract] [Full Text] [Related]
12. Addressing Pharmaceutical Price Spikes Through Generic Preclearance.
Sachs RE
J Leg Med; 2019; 39(2):169-176. PubMed ID: 31503530
[No Abstract] [Full Text] [Related]
13. It's time to bail out seniors trapped in the Medicare donut hole!
Dalen JE
Am J Med; 2009 Jul; 122(7):595-6. PubMed ID: 19559156
[No Abstract] [Full Text] [Related]
14. Prescription-drug coupons--no such thing as a free lunch.
Ross JS; Kesselheim AS
N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
[No Abstract] [Full Text] [Related]
15. Regulating Drug Prices while Increasing Innovation.
Conti RM; Frank RG; Gruber J
N Engl J Med; 2021 Nov; 385(21):1921-1923. PubMed ID: 34767322
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: Medicare Part D.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
[No Abstract] [Full Text] [Related]
17. Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.
Dusetzina SB; Conti RM; Yu NL; Bach PB
JAMA Intern Med; 2017 Aug; 177(8):1185-1188. PubMed ID: 28558108
[TBL] [Abstract][Full Text] [Related]
18. Federal drug discount program proves tricky for hospitals to navigate.
Thompson CA
Am J Health Syst Pharm; 2000 Dec; 57(23):2130, 2134, 2139-40. PubMed ID: 11127690
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals and Medical Devices: Medicare Part D.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-31. PubMed ID: 27116795
[No Abstract] [Full Text] [Related]
20. The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.
Duggan M; Morton FS
Am Econ Rev; 2010 Mar; 100(1):590-607. PubMed ID: 29508975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
